| J0490 | Injection, belimumab, 10 mg | 11,250 | $40 | $438.7K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 11,700 | $30 | $374.4K |
| J9312 | Injection, rituximab, 10 mg | 4,970 | $60 | $288.3K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 5,980 | $30 | $155.5K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 11,360 | $10 | $102.2K |
| 99215 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the… | 420 | $150 | $60.3K |
| 96365 | The provider administers the initial intravenous infusion of a medication or other substance for a period up to one hour to prevent, treat, or diagnose a condition or disease. | 540 | $60 | $31.4K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 260 | $120 | $31.1K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 190 | $110 | $20.9K |
| J3304 | Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg | 1,250 | $10 | $16.2K |